MedTrace Logo

Effect of Albumin Infusion on Oxidative Albumin Modification, Albumin Binding Capacity and Plasma Thiol Status

NCT03214796 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-03-06

No results posted yet for this study

Summary

The aim of this study is to investigate the effect of albumin infusion on oxidative albumin modification, on plasma thiol status and on albumin binding capacity for DS in patients who routinely receive albumin infusion for various indications and to relate these findings with neurohumoral parameters, bacterial products such as endotoxin, and neutrophil function

Conditions

  • Decompensated Cirrhosis

Interventions

DRUG

Human albumin

Infusion of human albumin

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Rudofl E Stauber, MD · Medical University of Graz

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-03
Primary Completion
2024-12-31
Completion
2024-12-31
FDA Drug
Yes

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03214796 on ClinicalTrials.gov